Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma

Published:2016 Issue:4 Volume:10 Page:181-187
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Xia Jufeng¹,Song Peipei²,Sun Zhipeng³,Sawakami Tatsuo¹,Jia Mingku⁴,Wang Zhigang⁴

Affiliation:

1. Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo

2. Graduate School of Frontier Sciences, The University of Tokyo

3. Oncology Surgery Department, Peking University Ninth School of Clinical Medicine

4. Hepato-Biliary-Pancreatic Surgery Division, The Second Affiliated Hospital of Jilin University

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/10/4/10_2016.01052/_pdf

Reference59 articles.

1. 1. World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed August 8, 2015).

2. 2. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011; 253:453-469.

3. 3. Song P, Tang W, Hasegawa K, Kokudo N. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan. Drug Discov Ther. 2014; 8:64-70.

4. 4. Ardiles V, Sanchez Claria R, Mazza OM, Ciardullo MA, Pekolj J, De Santibañes E. [Prognostic factors after resection of hepatocellular carcinoma in the non-cirrhotic liver: presentation of 51 cases]. Cir Esp. 2010; 87:148-154.

5. 5. Wang Z, Song P, Xia J, Inagaki Y, Tang W, Kokudo N. Can γ-glutamyl transferase levels contribute to a better prognosis for patients with hepatocellular carcinoma? Drug Discov Ther. 2014; 8:134-138.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional fluorescence/photoacoustic bimodal imaging of γ-glutamyltranspeptidase in liver disorders under different triggering conditions;Biomaterials;2024-10

2. Liver transplantation for hepatocellular carcinoma: a proposal for including preoperative serological indicators improves the Milan criteria expanded;2024-03-12

3. Interleukin-25 as a Potential Biomarker in Lung Metastasis of Hepatocellular Carcinoma with HBV History in Chinese Patients: A Single Center, Case-control Study;International Journal of Medical Sciences;2024

4. Near-infrared imaging of hepatocellular carcinoma and its medicinal treatment with a γ-glutamyl transpeptidase-monitoring fluorescence probe;Biosensors and Bioelectronics;2023-12

5. Targeting gamma-glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis;Free Radical Biology and Medicine;2023-11